Additive Formula 3 .28 g/100mL (Dextrose Monohydrate, TRISODIUM CITRATE DIHYDRATE, Sodium Chloride, SODIUM PHOSPHATE, MONOBASIC, MON SOLUTION) .28 g/100mL

Additive Formula 3 .28 g/100mL is a sterile intravenous solution containing Dextrose Monohydrate, TRISODIUM CITRATE DIHYDRATE, Sodium Chloride, and SODIUM PHOSPHATE, MONOBASIC, MON. This solution is designed for use in medical settings to support hydration and electrolyte balance. Ideal for healthcare professionals seeking reliable intravenous solutions.

Strength

.28 g/100mL

Pack Size

6 POUCH in 1 CASE (14537-832-03) / 6 BAG in 1 POUCH (14537-832-01) / 100 mL in 1 BAG (14537-832-00

Manufacturer / TM Owner

Terumo BCT, Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Additive Formula 3 .28 g/100mL is primarily used to maintain fluid and electrolyte balance in patients who require intravenous therapy. This solution is often utilized in clinical settings to support hydration and provide essential electrolytes. It is commonly administered to patients who are unable to maintain adequate oral intake or require additional fluid support.

Side Effects

When administered intravenously, Additive Formula 3 .28 g/100mL helps to replenish fluids and electrolytes in the body. This can contribute to maintaining proper hydration and supporting overall bodily functions. Patients may experience improved hydration and electrolyte balance following administration.

Precautions & Warnings

Additive Formula 3 .28 g/100mL should be handled with care and administered by healthcare professionals. It is important to follow proper aseptic techniques to prevent contamination. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

Additive Formula 3 .28 g/100mL may interact with other medications or treatments. It is important to inform healthcare providers of all current medications and treatments before administration. Patients should also be aware of potential interactions with other intravenous solutions or medications.

Frequently Asked Questions

Additive Formula 3 .28 g/100mL is used to maintain fluid and electrolyte balance in patients who require intravenous therapy.

Additive Formula 3 .28 g/100mL is administered intravenously by healthcare professionals in a clinical setting.

Common effects include improved hydration and electrolyte balance, supporting overall bodily functions.

Yes, it should be handled with care, administered by healthcare professionals, and proper aseptic techniques should be followed.

Yes, it may interact with other medications or treatments, so it is important to inform healthcare providers of all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.